Individual factors like age, weight, and baseline IGF-1 guide dose adjustments
The USA's Food and Drug Administration had warned against prescribing pimobendan before heart failure, and even its manufacturer included such warnings on the packaging
Semaglutide, a GLP-1 receptor agonist marketed as Ozempic, Wegovy, and Rybelsus, helps manage blood sugar and promotes weight loss
The official safety information for Ozempic does acknowledge a potential risk of thyroid cancer and thyroid tumors from the use of the diabetes drug
This frequent administration can lead to various challenges, such as patient non-compliance, injection-site reactions, immune responses, high costs, storage issues, and potential long-term safety concerns
Apr 20 2022;doi:10.7861/clinmed.2021-0764